Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients

Background Monoclonal antibodies against calcitonin gene-related peptides (CGRP) are innovative therapies for migraine treatment. Although they are clinically effective, how anti-CGRP treatment reduces migraine attacks still remains unclear. Objective In this observational case–control study, we aim...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cephalalgia 2023-08, Vol.43 (8), p.3331024231189751-3331024231189751
Hauptverfasser:	La Rocca, Marianna, Laporta, Anna, Clemente, Livio, Ammendola, Elena, Delussi, Marianna Diletta, Ricci, Katia, Tancredi, Giusy, Stramaglia, Sebastiano, de Tommaso, Marina
Format:	Artikel
Sprache:	eng
Schlagworte:	Calcitonin Gene-Related Peptide Case-Control Studies Double-Blind Method Electroencephalography Headache Humans Migraine Disorders - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!